M. Stevanovic-Walker

Anti-cancer actions of a recombinant antibody (R6313/G2) against the angiotensin II AT1 receptor.

J. Puddefoot, S. Barker, G. Vinson, 2008, Endocrine-related cancer.

Alternative promoters and repetitive DNA elements define the species-dependent tissue-specific expression of the FMO1 genes of human and mouse.

I. Phillips, E. Shephard, M. Edwards, 2007, The Biochemical journal.